ATE250673T1 - Verfahren zur identifizierung metastatischer sequenzen - Google Patents

Verfahren zur identifizierung metastatischer sequenzen

Info

Publication number
ATE250673T1
ATE250673T1 AT96942779T AT96942779T ATE250673T1 AT E250673 T1 ATE250673 T1 AT E250673T1 AT 96942779 T AT96942779 T AT 96942779T AT 96942779 T AT96942779 T AT 96942779T AT E250673 T1 ATE250673 T1 AT E250673T1
Authority
AT
Austria
Prior art keywords
sequences
cells
metastatic
probes
cell line
Prior art date
Application number
AT96942779T
Other languages
English (en)
Inventor
Timothy Thompson
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/594,031 external-priority patent/US5783182A/en
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Application granted granted Critical
Publication of ATE250673T1 publication Critical patent/ATE250673T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
AT96942779T 1995-11-16 1996-11-15 Verfahren zur identifizierung metastatischer sequenzen ATE250673T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US683895P 1995-11-16 1995-11-16
US08/594,031 US5783182A (en) 1996-01-30 1996-01-30 Method for identifying metastatic sequences
PCT/US1996/018567 WO1997018454A2 (en) 1995-11-16 1996-11-15 Method for identifying metastatic sequences

Publications (1)

Publication Number Publication Date
ATE250673T1 true ATE250673T1 (de) 2003-10-15

Family

ID=26676129

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96942779T ATE250673T1 (de) 1995-11-16 1996-11-15 Verfahren zur identifizierung metastatischer sequenzen

Country Status (6)

Country Link
EP (1) EP0870057B1 (de)
AT (1) ATE250673T1 (de)
AU (1) AU725186B2 (de)
CA (1) CA2237929A1 (de)
DE (1) DE69630142D1 (de)
WO (1) WO1997018454A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE38490E1 (en) 1995-11-16 2004-04-06 Baylor College Of Medicine Method for identifying metastatic sequences
USRE38392E1 (en) 1996-01-30 2004-01-20 Baylor College Of Medicine Method for identifying metastatic sequences
US6172211B1 (en) * 1997-07-11 2001-01-09 Boehringer Ingelheim International Gmbh Nucleic acid encoding tag7 polypeptide
US6277571B1 (en) 1997-10-03 2001-08-21 Virginia Commonwealth University Intellectual Property Foundation Sequential consensus region-directed amplification of known and novel members of gene families
US6252058B1 (en) 1997-11-05 2001-06-26 Timothy C. Thompson Sequences for targeting metastatic cells
CA2323074A1 (en) * 1998-03-13 1999-09-16 Baylor College Of Medicine Compositions and methods for the treatment and prevention of metastatic disorders
AU6531101A (en) 2000-06-02 2001-12-17 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1188839A1 (de) * 2000-09-19 2002-03-20 EVOTEC Neurosciences GmbH Verwendung von "Caveolae-Associated Integral " Membranprotein zur Diagnose und in Therapie von Alzheimer und verbundenen Neurodegenerativen Erkrankungen
JP2005516579A (ja) * 2000-12-08 2005-06-09 キュラジェン コーポレイション 障害に関連する結節硬化複合症の検出法および処置法
US20030120040A1 (en) 2001-06-29 2003-06-26 Genentech, Inc. Secreted and Transmembrane polypeptides and nucleic acids encoding the same
US7462491B2 (en) 2002-01-31 2008-12-09 Baylor College Of Medicine Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin
WO2004002516A1 (ja) * 2002-06-28 2004-01-08 Takeda Chemical Industries, Ltd. 呼吸器疾患の診断・予防・治療剤
CA2587670A1 (en) 2004-11-01 2006-05-11 George Mason University Compositions and methods for diagnosing colon disorders
JP2010514692A (ja) 2006-12-20 2010-05-06 バイエル ヘルスケア リミティド ライアビリティ カンパニー 癌の治療に有用なヒドロキシメチルフェニルピラゾリル尿素化合物
WO2011130728A1 (en) 2010-04-17 2011-10-20 Bayer Healthcare Llc Synthetic metabolites of fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention diseases and conditions
CA3146962A1 (en) * 2011-02-11 2012-08-16 The Rockefeller University Treatment of angiogenesis disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1181234B (it) * 1984-11-22 1987-09-23 Giovanni Zago Sistemi di pulizia automatica per videoregistratori e cassette di pulizia cosi' realizzate
IL77157A0 (en) * 1984-11-30 1986-04-29 Whitehead Biomedical Inst Detection and isolation of discrete transmissible,mammalian genes
GB9311130D0 (en) * 1993-05-28 1993-07-14 Isis Innovation Tumor metastasis gene
WO1995019369A1 (en) * 1994-01-14 1995-07-20 Vanderbilt University Method for detection and treatment of breast cancer
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor

Also Published As

Publication number Publication date
AU725186B2 (en) 2000-10-05
EP0870057A2 (de) 1998-10-14
DE69630142D1 (de) 2003-10-30
AU1160997A (en) 1997-06-05
CA2237929A1 (en) 1997-05-22
EP0870057B1 (de) 2003-09-24
WO1997018454A2 (en) 1997-05-22
WO1997018454A3 (en) 1997-08-14

Similar Documents

Publication Publication Date Title
DE69630142D1 (de) Verfahren zur identifizierung metastatischer sequenzen
DE69332642D1 (de) Methoden zur detektion von mikrometastasen bei prostata-krebs
ATE333517T1 (de) Verfahren und sondenset zur erkennung von krebs
DE69823347D1 (de) Mikrofluidisches system und verfahren zu dessen betrieb
NO20022945D0 (no) Fremgangsmåte for isolering av RNA fra formalin-fikserte paraffin-innstöpte vevspröver
ES2133813T3 (es) Cadenas de lamininas: diagnostico y uso terapeutico.
ATE328067T1 (de) Isolierung von mesenchymalen stammzellen und deren verwendung
ATE266723T1 (de) Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen
ATE515575T1 (de) Verfahren und sonden für den nachweis von krebs
DE69824004D1 (de) Verfahren zur quantitativen bestimmung der genexpression mit hilfe der multiplexen competitiven reversen-transkriptase polymerase kettenreaktion
DE3853678D1 (de) Verfahren zum nachweis des karzinogenen menschlichen papillomavirus.
TR199901667T2 (xx) 3-Heterosiklil-ikame edilmi� benzoil t�revleri
DE69808274D1 (de) Kombinationsprodukt, enthaltend eine nukleinsäure und eine substanz, die die extrazellulärematrix desorganisiert, zur verwendung in gentherapie
DE60028544D1 (de) Prostata-spezifische gene zur diagnose, prognose und behandlung von prostata-krebs
WO1999046385A3 (en) Compositions and methods for the treatment and prevention of metastatic disorders
BR9906926A (pt) Composições e métodos para tratamento de células tendo dna de minuto duplo
ATE428928T1 (de) Verfahren zur einführung von heterologischen zellen in fische
DE60043775D1 (de) Verfahren zum identifizieren von präneoplastischen und neoplastischen stadien in säugern
ATE466938T1 (de) Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs
DE59712871D1 (de) Heterocyclische verbindungen und deren verwendung in der detektion von nucleinsäuren
DE69506704D1 (de) Verfahren und proben zum nachweis von mit dem locus der infantilen spinalamyotrophien verbundenen markern
ATE495268T1 (de) Nukleinsäureamplifizierung und detektion von mykobacterium-spezies
ATE329055T1 (de) Methode zur erstellung von genexpressionsprofilen
PL329038A1 (en) Immunomagnetic separation of cells used for identification of genes associated with locally-selective formation of neoplasm metastases
ATE315107T1 (de) Verfahren und kit zur früherkennung von krebs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties